Ki16425
Ki16425 (Debio 0719) is a potent, reversible, and competitive antagonist of lysophosphatidic acid receptors LPA1, LPA2, and LPA3. It is widely used in both in vitro and in vivo research to investigate LPA signaling pathways in fields such as fibrosis, cancer, and neuropathic pain.
Product Specifications
CAS Number
355025-24-0
Product Name Alternative
LPA Receptor, LPA2, LPA1, LPAReceptor, LPA3, LPL, LPL Receptor, LPLReceptor, Lysophospholipid Receptor, inhibit, Ki16425, Ki-16425, Ki 16425, Inhibitor, Debio0719, Debio-0719, Debio 0719
Field of Research
Pharmacology & Drug Discovery, Stem Cell & Developmental Biology
Purity
96.15% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (6.95 mM) ; DMSO:94 mg/mL (197.91 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ; Ethanol:84 mg/mL (176.86 mM)
Smiles
CC (OC (=O) Nc1c (C) noc1-c1ccc (CSCCC (O) =O) cc1) c1ccccc1Cl
Molecular Formula
C23H23ClN2O5S
Molecular Weight
474.96
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
